Brent Meadows

Brent is a fractional Chief Business Officer leading the strategy and US business development and partnering efforts for multiple innovative biotech companies, including Hangzhou’s Polymed BioPharmaceuticals. Brent served as the CBO at OncoOne, where he defined the company’s overall business strategy and oversaw all aspects of business development including deal execution. Over his career, Brent has held senior level positions in business development, commercial strategy and marketing positions at Regeneron Pharmaceuticals, Bristol Myers Squibb Oncology, Biogen and several senior positions at Johnson and Johnson. While at AVEO Oncology and Baxalta/Shire he led or co-led multiple transactions each worth over $1 billion. He has an MBA from Babson College and a Bachelor’s of Science in Finance from the University of Richmond.